Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

F13A1 anticorps (AA 600-732)

F13A1 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN6140402
  • Antigène Voir toutes F13A1 Anticorps
    F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
    Épitope
    • 24
    • 8
    • 5
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 600-732
    Reactivité
    • 81
    • 8
    • 7
    • 3
    • 3
    Humain
    Hôte
    • 48
    • 33
    • 3
    • 1
    Lapin
    Clonalité
    • 50
    • 35
    Polyclonal
    Conjugué
    • 54
    • 6
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp F13A1 est non-conjugé
    Application
    • 47
    • 46
    • 32
    • 31
    • 24
    • 19
    • 15
    • 8
    • 7
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Séquence
    LEQASLHFFV TARINETRDV LAKQKSTVLT IPEIIIKVRG TQVVGSDMTV TVEFTNPLKE TLRNVWVHLD GPGVTRPMKK MFREIRPNST VQWEEVCRPW VSGHRKLIAS MSSDSLRHVY GELDVQIQRR PSM
     Réactivité croisée
    Humain, Souris, Rat
    Attributs du produit
    Polyclonal Antibodies
    Purification
    Affinity purification
    Immunogène
    Recombinant fusion protein containing a sequence corresponding to amino acids 600-732 of human F13A1 (NP_000120.2).
    Isotype
    IgG
    Top Product
    Discover our top product F13A1 Anticorps primaire
  • Indications d'application
    WB,1:500 - 1:2000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Avoid freeze / thaw cycles.
  • Antigène
    F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
    Autre désignation
    F13A1 (F13A1 Produits)
    Synonymes
    anticorps F13a, anticorps f13a1, anticorps wu:fo83d04, anticorps zgc:153334, anticorps F13A1, anticorps F13A, anticorps 1200014I03Rik, anticorps AI462306, anticorps coagulation factor XIII A1 chain, anticorps coagulation factor XIII, A1 polypeptide b, anticorps coagulation factor XIII A chain, anticorps coagulation factor XIII, A1 subunit, anticorps F13a1, anticorps f13a1b, anticorps F13A1
    Sujet
    This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits, and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion.,F13A1,F13A,Cardiovascular,Blood,Coagulation,Serum Proteins,F13A1
    Poids moléculaire
    83 kDa
    ID gène
    2162
    UniProt
    P00488
Vous êtes ici:
Support technique